RecruitingNCT04976348

The Multicenter Cardiology Monitoring Platform Registry

The Multicenter Cardiology Monitoring Platform Registry (mCMP-registry)

Sponsor

Maastricht University Medical Center

Enrollment

40,000 participants

Start Date

Jul 1, 2021

Study Type

OBSERVATIONAL

Conditions

Heart Failure Cardiomyopathies Atrial Fibrillation Coronary Artery Disease Ventricular Tachycardia Ventricular Arrythmia

Summary

The multicenter Cardiology Monitoring Platform registry (mCMP-registry) is a prospective observational registry including multi-omics (diagnostic) measurements performed as part of routine clinical care, bio-banking (optional), and yearly questionnaires (optional). It's objective is to optimize (early) diagnosis and risk-stratification of (early) cardiovascular diseases, specifically cardiomyopathy phenotypes, arrhythmias, and coronary artery disease, and to create a better understanding of underlying pathophysiological processes.

Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This is a registry study collecting data from people who visit cardiology or genetics clinics with heart failure symptoms or for heart screening. The goal is to build a large database that helps researchers understand genetic and other causes of heart failure. **You may be eligible if...** - You are 16 or older - You have been referred to cardiology or a genetics clinic for heart failure-like symptoms or cardiac/genetic screening **You may NOT be eligible if...** - You are unwilling to participate or unable to give written informed consent (e.g., due to language barriers or severe cognitive disability) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Maastricht UMC+

Maastricht, Limburg, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04976348

Related Trials

Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions

NCT067368998 locations

Feasibility Study of the FARAFLEX Mapping and PFA System

NCT065105564 locations

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288653 locations

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370638 locations

Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker

NCT075631531 location